{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:07:10Z","timestamp":1791252430125,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11897-012-0102-z","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T20:42:04Z","timestamp":1341520924000},"page":"164-173","source":"Crossref","is-referenced-by-count":86,"title":["AMP-activated Protein Kinase in the Control of Cardiac Metabolism and Remodeling"],"prefix":"10.1007","volume":"9","author":[{"given":"Sandrine","family":"Horman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vanoverschelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"102_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2741\/3229","volume":"14","author":"B Viollet","year":"2009","unstructured":"Viollet B, Athea Y, Mounier R, et al. AMPK: Lessons from transgenic and knockout animals. Front Biosci. 2009;14:19\u201344.","journal-title":"Front Biosci"},{"key":"102_CR2","doi-asserted-by":"crossref","first-page":"E780","DOI":"10.1152\/ajpendo.00443.2005","volume":"290","author":"K Sakamoto","year":"2006","unstructured":"Sakamoto K, Zarrinpashneh E, Budas GR, et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab. 2006;290:E780\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"102_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","volume":"2","author":"A Woods","year":"2005","unstructured":"Woods A, Dickerson K, Heath R, et al. Ca2+\/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2:21\u201333.","journal-title":"Cell Metab"},{"key":"102_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley SA, Pan DA, Mustard KJ, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2:9\u201319.","journal-title":"Cell Metab"},{"key":"102_CR5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cvr\/cvr034","volume":"90","author":"C Beauloye","year":"2011","unstructured":"Beauloye C, Bertrand L, Horman S, et al. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res. 2011;90:224\u201333.","journal-title":"Cardiovasc Res"},{"key":"102_CR6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart\u2013an engine out of fuel. N Engl J Med. 2007;356:1140\u201351.","journal-title":"N Engl J Med"},{"key":"102_CR7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","volume":"79","author":"L Bertrand","year":"2008","unstructured":"Bertrand L, Horman S, Beauloye C, et al. Insulin signalling in the heart. Cardiovasc Res. 2008;79:238\u201348.","journal-title":"Cardiovasc Res"},{"key":"102_CR8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/db06-0175","volume":"55","author":"JT Treebak","year":"2006","unstructured":"Treebak JT, Glund S, Deshmukh A, et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes. 2006;55:2051\u20138.","journal-title":"Diabetes"},{"key":"102_CR9","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/db06-0150","volume":"55","author":"HF Kramer","year":"2006","unstructured":"Kramer HF, Witczak CA, Fujii N, et al. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes. 2006;55:2067\u201376.","journal-title":"Diabetes"},{"key":"102_CR10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0960-9822(00)00742-9","volume":"10","author":"AS Marsin","year":"2000","unstructured":"Marsin AS, Bertrand L, Rider MH, et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol. 2000;10:1247\u201355.","journal-title":"Curr Biol"},{"key":"102_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-2760(96)00013-6","volume":"1301","author":"N Kudo","year":"1996","unstructured":"Kudo N, Gillespie JG, Kung L, et al. Characterization of 5\u2032AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta. 1996;1301:67\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"102_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","volume":"574","author":"JR Dyck","year":"2006","unstructured":"Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol. 2006;574:95\u2013112.","journal-title":"J Physiol"},{"key":"102_CR13","doi-asserted-by":"crossref","first-page":"H2875","DOI":"10.1152\/ajpheart.01032.2005","volume":"291","author":"E Zarrinpashneh","year":"2006","unstructured":"Zarrinpashneh E, Carjaval K, Beauloye C, et al. Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol. 2006;291:H2875\u201383.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR14","doi-asserted-by":"crossref","first-page":"H3136","DOI":"10.1152\/ajpheart.00683.2006","volume":"292","author":"K Carvajal","year":"2007","unstructured":"Carvajal K, Zarrinpashneh E, Szarszoi O, et al. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2007;292:H3136\u201347.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1172\/JCI19297","volume":"114","author":"RR Russell 3rd","year":"2004","unstructured":"Russell 3rd RR, Li J, Coven DL, et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004;114:495\u2013503.","journal-title":"J Clin Invest"},{"key":"102_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","volume":"104","author":"S Gundewar","year":"2009","unstructured":"\u2022\u2022 Gundewar S, Calvert JW, Jha S, et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104:403\u201311. This study demonstrates that low-dose metformin significantly improves left ventricular function and survival via activation of AMPK and its downstream mediators, eNOS and PGC-1alpha, in a model of heart failure. They used an AMPK dominant-negative mouse model to prove the implication of AMPK.","journal-title":"Circ Res"},{"key":"102_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2011.03.003","volume":"51","author":"AS Kim","year":"2011","unstructured":"\u2022 Kim AS, Miller EJ, Wright TM, et al. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury. J Mol Cell Cardiol. 2011;51:24\u201332. The authors were the first to show that treatment with a direct AMPK-activating molecule, the A-769662, is an effective strategy to protect the heart against ischemia\u2013reperfusion injury. They used an AMPK dominant-negative mouse model to prove the implication of AMPK.","journal-title":"J Mol Cell Cardiol"},{"key":"102_CR18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","volume":"57","author":"JW Calvert","year":"2008","unstructured":"Calvert JW, Gundewar S, Jha S, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008;57:696\u2013705.","journal-title":"Diabetes"},{"key":"102_CR19","doi-asserted-by":"crossref","first-page":"28372","DOI":"10.1074\/jbc.M303521200","volume":"278","author":"Y Xing","year":"2003","unstructured":"Xing Y, Musi N, Fujii N, et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem. 2003;278:28372\u20137.","journal-title":"J Biol Chem"},{"key":"102_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010;11:31\u20139.","journal-title":"Rev Endocr Metab Disord"},{"key":"102_CR21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167\u201374.","journal-title":"J Clin Invest"},{"key":"102_CR22","doi-asserted-by":"crossref","first-page":"H239","DOI":"10.1152\/ajpheart.01269.2005","volume":"291","author":"L Bertrand","year":"2006","unstructured":"Bertrand L, Ginion A, Beauloye C, et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol. 2006;291:H239\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR23","doi-asserted-by":"crossref","first-page":"H469","DOI":"10.1152\/ajpheart.00986.2010","volume":"301","author":"A Ginion","year":"2011","unstructured":"\u2022 Ginion A, Auquier J, Benton CR, et al. Inhibition of the mTOR\/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Am J Physiol Heart Circ Physiol. 2011;301:H469\u201377. In contrast to a commonly accepted notion, the authors showed that the insulin-sensitizing effect of AMPK on insulin-mediated glucose uptake is not due to the AMPK-induced inhibition of the mTOR\/p70S6K-dependent negative feedback loop.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR24","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00125-005-0016-3","volume":"48","author":"SL Longnus","year":"2005","unstructured":"Longnus SL, Segalen C, Giudicelli J, et al. Insulin signalling downstream of protein kinase B is potentiated by 5\u2032AMP-activated protein kinase in rat hearts in vivo. Diabetologia. 2005;48:2591\u2013601.","journal-title":"Diabetologia"},{"key":"102_CR25","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/en.2005-1433","volume":"147","author":"J Yang","year":"2006","unstructured":"Yang J, Holman GD. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology. 2006;147:2728\u201336.","journal-title":"Endocrinology"},{"key":"102_CR26","doi-asserted-by":"crossref","first-page":"38052","DOI":"10.1074\/jbc.M106703200","volume":"276","author":"F Tremblay","year":"2001","unstructured":"Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR\/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem. 2001;276:38052\u201360.","journal-title":"J Biol Chem"},{"key":"102_CR27","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab. 2009;296:E581\u201391.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"102_CR28","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1210\/en.2011-2099","volume":"153","author":"KM Habegger","year":"2012","unstructured":"Habegger KM, Hoffman NJ, Ridenour CM, et al. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol. Endocrinology. 2012;153:2130\u201341.","journal-title":"Endocrinology"},{"key":"102_CR29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4161\/auto.7.10.16740","volume":"7","author":"Z Xie","year":"2011","unstructured":"Xie Z, He C, Zou MH. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy. Autophagy. 2011;7:1254\u20135.","journal-title":"Autophagy"},{"key":"102_CR30","doi-asserted-by":"crossref","first-page":"H1165","DOI":"10.1152\/ajpheart.00486.2008","volume":"295","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Noguchi E, Ishida K, et al. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol. 2008;295:H1165\u201376.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp078","volume":"82","author":"Y Wang","year":"2009","unstructured":"Wang Y, Huang Y, Lam KS, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res. 2009;82:484\u201392.","journal-title":"Cardiovasc Res"},{"key":"102_CR32","doi-asserted-by":"crossref","first-page":"H2123","DOI":"10.1152\/ajpheart.00707.2010","volume":"300","author":"MA Paiva","year":"2011","unstructured":"Paiva MA, Rutter-Locher Z, Goncalves LM, et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2011;300:H2123\u201334.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR33","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1046\/j.1432-1033.2002.03074.x","volume":"269","author":"U Krause","year":"2002","unstructured":"Krause U, Bertrand L, Hue L. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem. 2002;269:3751\u20139.","journal-title":"Eur J Biochem"},{"key":"102_CR34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0960-9822(02)01077-1","volume":"12","author":"S Horman","year":"2002","unstructured":"Horman S, Browne G, Krause U, et al. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol. 2002;12:1419\u201323.","journal-title":"Curr Biol"},{"key":"102_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115:577\u201390.","journal-title":"Cell"},{"key":"102_CR36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30:214\u201326.","journal-title":"Mol Cell"},{"key":"102_CR37","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1074\/jbc.M309773200","volume":"279","author":"GJ Browne","year":"2004","unstructured":"Browne GJ, Finn SG, Proud CG. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem. 2004;279:12220\u201331.","journal-title":"J Biol Chem"},{"key":"102_CR38","doi-asserted-by":"crossref","first-page":"41970","DOI":"10.1074\/jbc.M302403200","volume":"278","author":"S Horman","year":"2003","unstructured":"Horman S, Beauloye C, Vertommen D, et al. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J Biol Chem. 2003;278:41970\u20136.","journal-title":"J Biol Chem"},{"key":"102_CR39","doi-asserted-by":"crossref","first-page":"H1242","DOI":"10.1152\/ajpheart.00859.2004","volume":"289","author":"SJ Crozier","year":"2005","unstructured":"Crozier SJ, Vary TC, Kimball SR, et al. Cellular energy status modulates translational control mechanisms in ischemic-reperfused rat hearts. Am J Physiol Heart Circ Physiol. 2005;289:H1242\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR40","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","volume":"279","author":"AY Chan","year":"2004","unstructured":"Chan AY, Soltys CL, Young ME, et al. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem. 2004;279:32771\u20139.","journal-title":"J Biol Chem"},{"key":"102_CR41","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","volume":"283","author":"AY Chan","year":"2008","unstructured":"Chan AY, Dolinsky VW, Soltys CL, et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem. 2008;283:24194\u2013201.","journal-title":"J Biol Chem"},{"key":"102_CR42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/HYPERTENSIONAHA.110.154732","volume":"56","author":"VW Dolinsky","year":"2010","unstructured":"\u2022 Dolinsky VW, Morton JS, Oka T, et al. Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension. 2010;56:412\u201321. The authors showed that short-term calorie restriction exerts beneficial effects in hypertensive rats via stimulation of an adiponectin\/AMPK\/eNOS signaling axis.","journal-title":"Hypertension"},{"key":"102_CR43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2008.09.057","volume":"376","author":"E Zarrinpashneh","year":"2008","unstructured":"Zarrinpashneh E, Beauloye C, Ginion A, et al. AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol. Biochem Biophys Res Commun. 2008;376:677\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"102_CR44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.108.114702","volume":"52","author":"P Zhang","year":"2008","unstructured":"Zhang P, Hu X, Xu X, et al. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension. 2008;52:918\u201324.","journal-title":"Hypertension"},{"key":"102_CR45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yjmcc.2010.02.021","volume":"49","author":"M Shimano","year":"2010","unstructured":"\u2022 Shimano M, Ouchi N, Shibata R, et al. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol. 2010;49:210\u201320. The authors showed that adiponectin deficiency accelerates the transition from cardiac hypertrophy to heart failure during pressure overload through disruption of AMPK-dependent angiogenic regulatory axis.","journal-title":"J Mol Cell Cardiol"},{"key":"102_CR46","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","volume":"284","author":"Y Ikeda","year":"2009","unstructured":"Ikeda Y, Sato K, Pimentel DR, et al. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J Biol Chem. 2009;284:35839\u201349.","journal-title":"J Biol Chem"},{"key":"102_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2011.04.010","volume":"511","author":"R Meng","year":"2011","unstructured":"Meng R, Pei Z, Zhang A, et al. AMPK activation enhances PPARalpha activity to inhibit cardiac hypertrophy via ERK1\/2 MAPK signaling pathway. Arch Biochem Biophys. 2011;511:1\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"102_CR48","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcb.21197","volume":"100","author":"HL Li","year":"2007","unstructured":"Li HL, Yin R, Chen D, et al. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J Cell Biochem. 2007;100:1086\u201399.","journal-title":"J Cell Biochem"},{"key":"102_CR49","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/aps.2010.73","volume":"31","author":"BL Chen","year":"2010","unstructured":"Chen BL, Ma YD, Meng RS, et al. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1\/MuRF1 signaling pathway in vitro. Acta Pharmacol Sin. 2010;31:798\u2013804.","journal-title":"Acta Pharmacol Sin"},{"key":"102_CR50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2009.08.024","volume":"620","author":"RS Meng","year":"2009","unstructured":"Meng RS, Pei ZH, Yin R, et al. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway. Eur J Pharmacol. 2009;620:63\u201370.","journal-title":"Eur J Pharmacol"},{"key":"102_CR51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","volume":"367","author":"LH Opie","year":"2006","unstructured":"Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling. Lancet. 2006;367:356\u201367.","journal-title":"Lancet"},{"key":"102_CR52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfr071","volume":"13","author":"R Knoll","year":"2011","unstructured":"Knoll R, Iaccarino G, Tarone G, et al. Towards a re-definition of \u2018cardiac hypertrophy\u2019 through a rational characterization of left ventricular phenotypes: a position paper of the Working Group \u2018Myocardial Function\u2019 of the ESC. Eur J Heart Fail. 2011;13:811\u20139.","journal-title":"Eur J Heart Fail"},{"key":"102_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"102_CR54","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","volume":"291","author":"TA Baudino","year":"2006","unstructured":"Baudino TA, Carver W, Giles W, et al. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol. 2006;291:H1015\u201326.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.hfc.2011.08.012","volume":"8","author":"SR Eckhouse","year":"2012","unstructured":"Eckhouse SR, Spinale FG. Changes in the myocardial interstitium and contribution to the progression of heart failure. Heart Fail Clin. 2012;8:7\u201320.","journal-title":"Heart Fail Clin"},{"key":"102_CR56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","volume":"120","author":"N Takeda","year":"2010","unstructured":"Takeda N, Manabe I, Uchino Y, et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest. 2010;120:254\u201365.","journal-title":"J Clin Invest"},{"key":"102_CR57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/jmcc.1996.0014","volume":"28","author":"SP Bishop","year":"1996","unstructured":"Bishop SP, Powell PC, Hasebe N, et al. Coronary vascular morphology in pressure-overload left ventricular hypertrophy. J Mol Cell Cardiol. 1996;28:141\u201354.","journal-title":"J Mol Cell Cardiol"},{"key":"102_CR58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.00042.2007","volume":"89","author":"JL Balligand","year":"2009","unstructured":"Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev. 2009;89:481\u2013534.","journal-title":"Physiol Rev"},{"key":"102_CR59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","volume":"87","author":"FG Spinale","year":"2007","unstructured":"Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev. 2007;87:1285\u2013342.","journal-title":"Physiol Rev"},{"key":"102_CR60","doi-asserted-by":"crossref","first-page":"H1883","DOI":"10.1152\/ajpheart.00514.2007","volume":"293","author":"I Banerjee","year":"2007","unstructured":"Banerjee I, Fuseler JW, Price RL, et al. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 2007;293:H1883\u201391.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"102_CR61","first-page":"353","volume":"18","author":"N Sugihara","year":"1988","unstructured":"Sugihara N, Genda A, Shimizu M, et al. Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension. J Cardiol. 1988;18:353\u201361.","journal-title":"J Cardiol"},{"key":"102_CR62","doi-asserted-by":"crossref","unstructured":"Bian ZY, Wei X, Deng S, et al.: Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. J Mol Med (Berl) 2012. doi: 10.1007\/s00109-012-0883-2 .","DOI":"10.1007\/s00109-012-0883-2"},{"key":"102_CR63","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.CIR.100.10.1116","volume":"100","author":"K Kuwahara","year":"1999","unstructured":"Kuwahara K, Saito Y, Harada M, et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation. 1999;100:1116\u201324.","journal-title":"Circulation"},{"key":"102_CR64","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1161\/01.CIR.96.10.3737","volume":"96","author":"M Harada","year":"1997","unstructured":"Harada M, Itoh H, Nakagawa O, et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation. 1997;96:3737\u201344.","journal-title":"Circulation"},{"key":"102_CR65","doi-asserted-by":"crossref","first-page":"29717","DOI":"10.1074\/jbc.M003128200","volume":"275","author":"M Sano","year":"2000","unstructured":"Sano M, Fukuda K, Kodama H, et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000;275:29717\u201323.","journal-title":"J Biol Chem"},{"key":"102_CR66","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","volume":"115","author":"I Shiojima","year":"2005","unstructured":"Shiojima I, Sato K, Izumiya Y, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108\u201318.","journal-title":"J Clin Invest"},{"key":"102_CR67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvr305","volume":"93","author":"A Kazakov","year":"2012","unstructured":"Kazakov A, Muller P, Jagoda P, et al. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis. Cardiovasc Res. 2012;93:397\u2013405.","journal-title":"Cardiovasc Res"},{"key":"102_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","volume":"555","author":"R Ventura-Clapier","year":"2004","unstructured":"Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol. 2004;555:1\u201313.","journal-title":"J Physiol"},{"key":"102_CR69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093\u2013129.","journal-title":"Physiol Rev"},{"key":"102_CR70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MCO.0b013e32833a55a5","volume":"13","author":"AT Turer","year":"2010","unstructured":"Turer AT, Malloy CR, Newgard CB, et al. Energetics and metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr Metab Care. 2010;13:458\u201365.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"102_CR71","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","volume":"116","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116:434\u201348.","journal-title":"Circulation"},{"key":"102_CR72","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0735-1097(02)02160-5","volume":"40","author":"M Beer","year":"2002","unstructured":"Beer M, Seyfarth T, Sandstede J, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"102_CR73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1006876031121","volume":"180","author":"RC Starling","year":"1998","unstructured":"Starling RC, Hammer DF, Altschuld RA. Human myocardial ATP content and in vivo contractile function. Mol Cell Biochem. 1998;180:171\u20137.","journal-title":"Mol Cell Biochem"},{"key":"102_CR74","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/01.CIR.0000036760.42319.3F","volume":"106","author":"H Taegtmeyer","year":"2002","unstructured":"Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation. 2002;106:2043\u20135.","journal-title":"Circulation"},{"key":"102_CR75","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","volume":"297","author":"L Hue","year":"2009","unstructured":"Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab. 2009;297:E578\u201391.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"102_CR76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207\u201358.","journal-title":"Physiol Rev"},{"key":"102_CR77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvq240","volume":"88","author":"MG Rosca","year":"2010","unstructured":"Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res. 2010;88:40\u201350.","journal-title":"Cardiovasc Res"},{"key":"102_CR78","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cvr\/cvn098","volume":"79","author":"R Ventura-Clapier","year":"2008","unstructured":"Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res. 2008;79:208\u201317.","journal-title":"Cardiovasc Res"},{"key":"102_CR79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","volume":"1","author":"Z Arany","year":"2005","unstructured":"Arany Z, He H, Lin J, et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005;1:259\u201371.","journal-title":"Cell Metab"},{"key":"102_CR80","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","volume":"103","author":"Z Arany","year":"2006","unstructured":"Arany Z, Novikov M, Chin S, et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A. 2006;103:10086\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"102_CR81","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","volume":"3","author":"TC Leone","year":"2005","unstructured":"Leone TC, Lehman JJ, Finck BN, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005;3:e101.","journal-title":"PLoS Biol"},{"key":"102_CR82","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/hc4001.097183","volume":"104","author":"R Tian","year":"2001","unstructured":"Tian R, Musi N, D\u2019Agostino J, et al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation. 2001;104:1664\u20139.","journal-title":"Circulation"},{"key":"102_CR83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbadis.2010.04.008","volume":"1802","author":"N Jessen","year":"2010","unstructured":"Jessen N, Koh HJ, Folmes CD, et al. Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function. Biochim Biophys Acta. 2010;1802:593\u2013600.","journal-title":"Biochim Biophys Acta"},{"key":"102_CR84","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1152\/japplphysiol.01293.2009","volume":"108","author":"DM Thomson","year":"2010","unstructured":"Thomson DM, Hancock CR, Evanson BG, et al. Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice. J Appl Physiol. 2010;108:1775\u201385.","journal-title":"J Appl Physiol"},{"key":"102_CR85","first-page":"583","volume":"62","author":"A Ahluwalia","year":"2011","unstructured":"Ahluwalia A. Tarnawski AS: Activation of the metabolic sensor-AMP activated protein kinase reverses impairment of angiogenesis in aging myocardial microvascular endothelial cells. Implications for the aging heart. J Physiol Pharmacol. 2011;62:583\u20137.","journal-title":"J Physiol Pharmacol"},{"key":"102_CR86","doi-asserted-by":"crossref","first-page":"31000","DOI":"10.1074\/jbc.M300643200","volume":"278","author":"D Nagata","year":"2003","unstructured":"Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem. 2003;278:31000\u20136.","journal-title":"J Biol Chem"},{"key":"102_CR87","doi-asserted-by":"crossref","first-page":"22291","DOI":"10.1074\/jbc.M110.123794","volume":"285","author":"K Ohashi","year":"2010","unstructured":"Ohashi K, Ouchi N, Higuchi A, et al. LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J Biol Chem. 2010;285:22291\u20138.","journal-title":"J Biol Chem"},{"key":"102_CR88","doi-asserted-by":"crossref","first-page":"E834","DOI":"10.1152\/ajpendo.00234.2004","volume":"287","author":"J Li","year":"2004","unstructured":"Li J, Hu X, Selvakumar P, et al. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab. 2004;287:E834\u201341.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"102_CR89","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bjp.0705367","volume":"139","author":"S Gschwend","year":"2003","unstructured":"Gschwend S, Henning RH, Pinto YM, et al. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol. 2003;139:1317\u201325.","journal-title":"Br J Pharmacol"},{"key":"102_CR90","doi-asserted-by":"crossref","first-page":"18505","DOI":"10.1074\/jbc.M802053200","volume":"283","author":"S Horman","year":"2008","unstructured":"Horman S, Morel N, Vertommen D, et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem. 2008;283:18505\u201312.","journal-title":"J Biol Chem"},{"key":"102_CR91","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad F, Alla F, Dousset B, et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation. 2000;102:2700\u20136.","journal-title":"Circulation"},{"key":"102_CR92","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.105.600353","volume":"114","author":"CS Webb","year":"2006","unstructured":"Webb CS, Bonnema DD, Ahmed SH, et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation. 2006;114:1020\u20137.","journal-title":"Circulation"},{"key":"102_CR93","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1074\/jbc.M110.199398","volume":"286","author":"Y Morizane","year":"2011","unstructured":"Morizane Y, Thanos A, Takeuchi K, et al. AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts. J Biol Chem. 2011;286:16030\u20138.","journal-title":"J Biol Chem"},{"key":"102_CR94","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.1074\/jbc.M800902200","volume":"283","author":"R Mishra","year":"2008","unstructured":"Mishra R, Cool BL, Laderoute KR, et al. AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem. 2008;283:10461\u20139.","journal-title":"J Biol Chem"},{"key":"102_CR95","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1073\/pnas.0610157104","volume":"104","author":"B Zheng","year":"2007","unstructured":"Zheng B, Cantley LC. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc Natl Acad Sci U S A. 2007;104:819\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"102_CR96","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1073\/pnas.0608531103","volume":"103","author":"L Zhang","year":"2006","unstructured":"Zhang L, Li J, Young LH, et al. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci U S A. 2006;103:17272\u20137.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-012-0102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-012-0102-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-012-0102-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T09:11:11Z","timestamp":1642669871000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-012-0102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1007\/s11897-012-0102-z","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]}}}